Significant increase in volume has been observed in Orchid Pharma Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Orchid Pharma Limited has submitted their response.
ORCHPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The National Stock Exchange flagged a sharp rise in trading volume of Orchid Pharma shares and asked the company to clarify the reason. Orchid Pharma replied on November 4, 2025, stating that it has no undisclosed information, pending announcements, or upcoming corporate actions that could explain the volume spike. The company confirmed full compliance with SEBI's listing and disclosure rules. This is a standard surveillance clarification, not an enforcement action.
Neutral for shareholders. The company has nothing new to share, so the volume spike remains unexplained publicly. Investors should watch for any follow-up disclosures, but at present there is no positive or negative catalyst identified by the company itself.